Your browser doesn't support javascript.
loading
Bortezomib, a promising alternative for patients with refractory or relapsed thrombotic thrombocytopenic purpura after rituximab treatment.
Yin, Jie; Tian, Hong; Kong, Danqing; Li, Yun; Gu, Chengyuan; Wang, Zhaoyue; Wu, Depei; Yu, Ziqiang.
Afiliação
  • Yin J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
  • Tian H; NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Kong D; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Li Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
  • Gu C; NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Wang Z; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Wu D; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
  • Yu Z; NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China.
Br J Haematol ; 199(4): 619-622, 2022 11.
Article em En | MEDLINE | ID: mdl-36076349
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Trombótica Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Trombótica Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China